The invention relates to a pressure-stable cylinder/piston unit which blocks water vapor and oxygen and is designed for a needle-free injector, with a chamber arranged in a cylinder, which blocks water vapor and oxygen, and designed for long-term and sterile storage of an injection solution, an end wall with at least one nozzle bore or one outlet element, a pressure-stable outer cylinder, and a pressure-stable piston arranged movably in the chamber and blocking water vapor and oxygen.
The invention further relates to methods for bubble-free, automatic or manual filling of the cylinder/piston unit, also at atmospheric pressure.
Cylinder/piston units are used in injectors and disposable injectors which are known, for example, from US 2008/0146997 A1, DE 10 2007 004 211 A1 or DE 10 2007 008 369 A1. None of these cylinder/piston units is suitable for long-term storage of injection solutions, e.g. over a year, since they are unable to block water vapor and oxygen.
Injection solution is understood as liquid medicaments. The specialist terms used will now be explained in detail. The term medicament is known to the person skilled in the art. This is understood as substances or mixtures of substances for human or veterinary medicine. They consist of the pharmaceutical active substance or substances, and of further standard components that make this active substance usable pharmaceutically, in particular water.
DE 10 2005 054 600 A1 discloses a cylinder/piston unit having a cylinder and a piston which is guided therein, wherein the cylinder and the piston enclose a chamber that can be filled at least for a time with an active substance, and the cylinder has at least one outlet element at its front end. The cross section of the chamber or the cross section of the cylinder inner wall increases at least in regions from the front to the back. At least in the front area directed toward the outlet element, the piston has a front elastic skirt, the front outer edge of which defines, when the piston is unloaded, a cross-sectional surface which is greater than a surface that is defined by a contour line and that lies in the area of transition from the skirt to the section of the piston carrying the skirt.
DE 10 2006 040 888 B3 discloses a closure system for containers used for storing or administering substances in the form of liquids, pastes or powders, said system consisting of a cap, provided with a through-hole, and of a closure element. The cap holds the closure element with a force fit and/or form fit on the container by means of a catch element present on the container in the area of the opening that is to be closed. The end face which surrounds the opening of the container, and on which the closure element bears, has a depression. The closure element is a virus-proof, bacteria-proof and spore-proof film that lies on the end face and, at least in some areas, over the depression. When the cap is fitted in place, an elastomer ring or adhesive ring is arranged between the closure element and the depression and fills the depression.
DE 10 2006 045 959 B3 discloses a cylinder/piston unit including a cylinder and a piston guided in the cylinder and sealed off in a sterile manner by a rubber seal, wherein the cylinder and the piston enclose a chamber that can be filled at least for a time with active substance, and the cylinder has at least one outlet element at its front end. The piston, resting in a rear position, is sealed off relative to the cylinder in a sterile manner by a static rear sealing element, wherein both sealing elements each respectively bear on the wall of the cylinder and on the wall of the piston in a sealing position. Arranged spatially behind each static sealing element, there is a parking area for receiving the respective sealing element. When the piston is actuated, the individual static sealing elements are transferred from their respective sealing position to a parked position located in the parking area, wherein each sealing element in the parked position touches either only the cylinder wall or only the piston wall. Arranged between the two static sealing elements, there is at least one dynamic sealing element on the piston side, which dynamic sealing element bears on the inner wall of the cylinder at least when the piston is actuated.
In the described cylinder/piston unit, a closure element is inserted as a piston into the prefilled medicament chamber in the vacuum application process. Under vacuum, the closure element is placed on the liquid level of the medicament that has been introduced into the chamber. This method and the devices required for it are expensive and complicated.
Proceeding from this prior art, the objects of the invention are
These objects are achieved in the first instance by the method of claim 1. Accordingly, the pressure-stable cylinder/piston unit which blocks water vapor and oxygen is characterized in that the chamber is designed with a first chamber and a second, concentric chamber, wherein the cross section of the first chamber is greater than the cross section of the second chamber, and each nozzle bore or each outlet element is closed in a sterile manner by a membrane that blocks water vapor and oxygen and that opens at an overpressure. By means of such a configuration, a contact surface or annular surface is created on which the piston comes to bear, e.g. with a U-profile seal that is squeezed upon insertion into the first chamber and allows air to escape.
Object 2 is achieved by the design of the nozzle outlet.
The nozzle outlet ends in a raised (protruding) truncated cone, such that the skin is pressed on during injection, and the injection solution penetrates the skin at relatively low pressure. This is helped by the underlying subcutaneous fatty tissue, which constitutes looser tissue compared to the cutis. Since the stream of injection solution does not impact the skin in free flight, it also cannot partially or completely rebound off the surface. It is quantitatively administered, and a wet-shot is avoided.
Object 3 is achieved by plug-like closure of the skin. Since the nozzle outlet is closed by the piston, in particular the inner piston body, the raised truncated cone forms a plug at the injection site. If it is left in place for a few seconds on the skin until the pressure in the skin has dropped as a result of the distribution of the injection solution, no return flow can occur.
Object 4 is achieved by a multi-nozzle model, e.g. a four-nozzle model, such that up to 0.6 milliliter can be administered free of bubbles. Experience shows that needle-free subcutaneous injections with volumes of greater than 150 microliters cause subcutaneous bubble formation. The version presented here by way of example has four outlet elements and is therefore able to administer injection volumes of up to 0.6 milliliter.
By a preferred embodiment of the piston in an inner piston body with flange and an outer piston ring that blocks water vapor and oxygen and provides a sterile seal, for example in the form of a U-profile or of a sterile seal with another shape that overlaps the flange blocking water vapor and oxygen, different materials may be considered for the piston. For closing the chamber, or the second chamber filled with injection solution, and for the subsequent possible storage for up to one year, the outer piston ring is made of a rubber approved for medicine, e.g. West 4590. Upon insertion into the first chamber, the outer piston ring is pressed such that a channel or a flow edge arises through which the displaced air can escape from the chamber without pressure. A gas cushion, located entirely in the second chamber, remains between the piston and the injection solution. In a further step, this gas cushion is removed from the second chamber by means of the chamber being inverted (air to nozzle) and the inner piston body of the piston being pressed into the second chamber. The flange and the external diameter of the inner piston body are adapted to the internal diameter of the second chamber. When air is removed completely from the second chamber, the inner piston body is located entirely within the second chamber. The guiding of the inner piston body is at all times ensured by a configuration of this kind.
During the subsequent injection of the injection solution by means of a drive unit, the cylinder/piston unit is received by, for example, spring hooks of the drive unit. An alternative embodiment involves screwing the cylinder/piston unit into the drive unit, providing it with a flange or bayonet closure.
For the injection, the engaged closure cap with the membrane fitted over it is removed, and, with the aid of the piston rod actuated by the drive unit (for example by a pretensioned spring), the inner piston body with flange is pushed in as far as the end of the second chamber and so quickly that the speed of the stream of liquid emerging from the nozzle(s) is sufficient for penetration of the skin.
In a preferred embodiment, the inner piston body is designed with at least one sealing lip, wherein the leak tightness between the inner piston body and the wall of the second chamber increases as the pressure rises.
The abovementioned object is also achieved by a method using the cylinder/piston unit just described above. The method comprises at least the following steps:
The method ensures that the cylinder/piston unit is completely filled and that, without further measures, it can be separately stored or can be used in a drive unit. Providing the closure cap with a membrane ensures at all times that the injection solution remains sealed in a sterile manner at three places on the annular pressure contours A, B and C.
For manual filling, e.g. for clinical tests, the piston is positioned about 2-3 mm in front of the annular surface. With the nozzle pointing upward, the injection solution is injected through the outer piston ring into the chamber. By advancing the piston as far as the annular surface, and by further advancing the inner piston body with flange, the air is forced through the overpressure valve formed by the membrane.
In a development of the method, it is proposed that the complete emergence of the gas cushion is detected. For this purpose, for example, the nozzle bore(s) or outlet element(s) is/are monitored by a light barrier for the emergence of the injection liquid. As soon as a change is detected, the insertion of the inner piston body is directly stopped.
Since the air requires a much lower advancing force of the piston than does the injection solution, the switching-off of the piston advance can also be thereby controlled.
With the present-day accuracy of liquid metering and the precision of injection-molded chambers, it is also possible to compute the advance movement of the piston rod. In the case of small batch numbers, the movement of the air bubble is monitored by sight.
Further features and details of the invention will become clear from an illustrative embodiment depicted in schematic drawings, in which:
In all of the figures, the same technical elements are designated by the same reference signs.
Between the first chamber 8 and the second chamber 9, a transition area is formed, preferably as an interior annular surface 16 of cylinder 2. A first embodiment of the transition area provides radii (not shown) at the transition from the cylindrical wall of the first chamber 8 to the annular surface 16 and from the annular surface 16 to the cylindrical wall of the second chamber 9. A second embodiment of this area provides bevels (not shown). Other embodiments, including combinations of, for example, radii and bevels, negative or positive camber, and concave or convex, can be considered. The embodiments help, on the one hand, when filling the injection solution 4 (see
Using known devices, the injection solution 4 is introduced into the second chamber 9 in such a way that the second chamber 9 is not completely filled. The filling is carried out under atmospheric pressure. The filling of each cylinder 2 is carried out separately or in groups, wherein, for example, twenty cylinders in a matrix of four×five in a tray are filled simultaneously.
A piston 7 as a multi-part closure element is then pushed into the first chamber 8 at atmospheric pressure, as is shown in
After placement of the piston 7, composed of the outer piston ring 17 and of the inner piston body 18 with flange 22, which can also be designed separately from a piston rod 21, a gas bubble/air pocket 19 and the injection solution 4 are located in the second chamber 9. To remove the gas bubble/air pocket 19, the cylinder/piston unit 1 is rotated through ca. 180° about the horizontal axis. The end wall 5, with the attached closure cap 10 and the membrane 26, now points upward, as is shown in
As is shown in
Besides glass, suitable materials for the cylinder 2 and the flange 22 are also transparent, amorphous thermoplastics, e.g. a copolymer based on cycloolefins and ethylenes or α-olefins (COC or COP).
The outer cylinder 13 has to be able to withstand for a short time (a few milliseconds) a pressure of up to 350 bar and must therefore be made of a pressure-stable material, for example polycarbonate (PC) or polyurethane (PU).
The material used for the inner piston body 18 is a tetrafluoroethylene/hexafluoropropylene copolymer (FEP). This has self-lubricating properties in conjunction with the aforementioned materials of the cylinder 2 or inner part, such that no separate lubricants are needed between the inner piston body 18 and the cylinder 2. Alternative materials that can be chosen include perfluoroalkoxy copolymer (PFA), tetrafluoroethylene (E TFE) or polyvinylidene fluoride (PVDF).
The material used for the outer piston ring 17 is a rubber, such as Helveot FM 257, Heivoet FM 460, Stelmi 6422, Stelmi 6720 or West 4590. The membrane 26 can be made of the same materials that close in a sterile manner and block water vapor and oxygen.
In the same way as is shown in
Number | Date | Country | Kind |
---|---|---|---|
10 2009 023 334 | May 2009 | DE | national |
This is a divisional of and claims the benefit of U.S. patent application Ser. No. 13/304,469 filed Nov. 25, 2011, now U.S. Pat. No. 8,597,233 B2 dated Dec. 3, 2013, which application is incorporated herein by reference in its entirety. The said U.S. patent application Ser. No. 13/304,469 is a continuation-in-part application of pending international application PCT/EP2010/002975 filed May 14, 2010 and claiming the priority of German Application No. 10 2009 023 334.2 filed May 29, 2009.
Number | Name | Date | Kind |
---|---|---|---|
5312335 | McKinnon et al. | May 1994 | A |
5626567 | Gmeiner | May 1997 | A |
20050240159 | Kito et al. | Oct 2005 | A1 |
20080146997 | Hoffmann | Jun 2008 | A1 |
20080287885 | Hoffmann et al. | Nov 2008 | A1 |
20090166978 | Hoffmann et al. | Jul 2009 | A1 |
20090281496 | Matusch | Nov 2009 | A1 |
Number | Date | Country |
---|---|---|
0 551 183 | Oct 1998 | EP |
1 557 190 | Jul 2005 | EP |
1 875 934 | Jan 2008 | EP |
2 613 628 | Apr 1987 | FR |
WO 2006128915 | Dec 2006 | WO |
Entry |
---|
U.S. Appl. No. 2009/0159553 A1-Date: Jun. 25, 2009; Name: Hans-Rainer Hoffmann, et al. |
U.S. Appl. No. 2009/0254036-Date: Oct. 8, 2009; Name: Bado Asmussen, et al. |
Number | Date | Country | |
---|---|---|---|
20140096865 A1 | Apr 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13304469 | Nov 2011 | US |
Child | 14063037 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/EP2010/002975 | May 2010 | US |
Child | 13304469 | US |